FDA Issues Draft Guidance on Device Changes that Trigger New Review
The Food and Drug Administration has issued draft guidance that clarifies the kinds of changes or modifications to a previously cleared 510(k) device that trigger the need for a new premarket submission, such as changes regarding labeling, the technology used…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
in the device, performance specifications, manufacturing changes, etc. To legally market a device, manufacturers must submit a premarket notification or 510(k) demonstrating that a new or modified product is substantially equivalent to another legally marketed medical device. When manufacturers make changes or modifications to a device after FDA clearance that could significantly affect the product’s safety or effectiveness or constitute a major change to the intended use of the device, another 510(k) must be submitted.